Christi Grimm interview, Crisis at HHS, Medicare rates

STAT has recently been awarded a National Magazine Award for General Excellence, underscoring the hard work and dedication of its staff. This achievement highlights the value and reliability of STAT as a trusted source of news for its subscribers. If you want to stay informed about the latest health care developments, consider signing up for their email newsletter.

One significant event that has garnered attention is the abrupt firing of Christi Grimm, the inspector general overseeing the Department of Health and Human Services. Grimm, along with seven other inspectors general, has filed a lawsuit against President Trump and his administration, alleging that their terminations were unlawful. This situation raises concerns about the independence of inspectors general and the potential impact on efforts to combat fraud and abuse in health care programs.

Grimm’s insights into Medicare Advantage, where she highlighted issues with insurers’ practices, shed light on the critical role of inspectors general in ensuring accountability and transparency in health care. Her firing serves as a reminder of the ongoing challenges faced by those tasked with overseeing government programs.

In other news, the Medicare Advantage industry recently received a significant pay raise for 2026, driven by changes in spending data. This development raises questions about the structure of Medicare Advantage payments and their alignment with the broader health care landscape. The article discusses the implications of tying payments to traditional Medicare data and the need for a more nuanced approach to reimbursement.

The Department of Health and Human Services has been experiencing upheaval under the current administration, with agencies like the CDC, FDA, and NIH facing challenges in resource allocation. Despite these difficulties, Medicare and Medicaid payments have remained stable, ensuring continued support for essential health care services. The impact of these changes on various HHS programs is explored in detail, providing insights into the broader implications for health care delivery.

Looking ahead, upcoming earnings calls from major health care companies like UnitedHealth Group and Merck offer insights into industry trends and financial performance. These calls provide a snapshot of the health care landscape and offer valuable information for investors and stakeholders.

In a surprising turn of events, Regeneron Pharmaceuticals disclosed expenses related to residential internet upgrades for its executives. This unusual expenditure underscores the importance of connectivity in today’s digital age and the evolving demands placed on health care leaders.

Lastly, industry developments such as proposed Medicare payment rates for hospitals, allegations of cartel-like behavior in data companies, and rising costs of medical products highlight ongoing challenges in the health care sector. These issues underscore the need for continued vigilance and oversight to ensure the sustainability and integrity of health care systems.

Overall, this edition of Health Care Inc. offers a comprehensive overview of current events and trends in the health care industry. From regulatory changes to financial updates, the newsletter provides valuable insights for readers interested in staying informed about the evolving health care landscape. The American Medical Association (AMA) has sent a letter to UnitedHealth, urging the insurance company to hold off on collecting payments until physicians determine it is the appropriate time. The AMA emphasizes that physicians have relied on UnitedHealth’s statements and need the flexibility to make decisions based on medical necessity.

In 2021, Medicare Advantage insurers generated $33 billion by adding diagnosis codes to patients’ medical records. UnitedHealth alone accounted for 42% of that total, indicating the significant impact the company has on the healthcare industry.

Recently, there has been a growing call for reforms in the Medicare Advantage program, even from traditionally supportive Republicans. Rep. Mike Kennedy of Utah, a family medicine doctor, shared his experience of receiving reports from UnitedHealth’s HouseCalls programs. He expressed frustration and disregard for the reports, highlighting concerns about the program’s practices.

In Arkansas, lawmakers are considering a proposal to prohibit pharmacy benefit managers from owning mail-order or retail pharmacies. This move aims to address potential conflicts of interest and ensure fair competition in the pharmacy industry.

On another front, employee-led lawsuits seeking to hold employers accountable for inflated drug spending have faced challenges in court. Attorneys representing the employees are adjusting their legal arguments to address judges’ concerns and improve the chances of success in these cases.

The healthcare landscape is constantly evolving, with stakeholders pushing for transparency, accountability, and fair practices. The AMA’s letter to UnitedHealth underscores the importance of collaboration between insurers and healthcare providers to ensure patient-centered care and ethical business practices.

In conclusion, the healthcare industry is facing scrutiny and calls for reform, with various stakeholders advocating for change to improve transparency and accountability. UnitedHealth and other insurers must work closely with physicians and regulators to address concerns and uphold the highest standards of care for patients.